Why Is McKesson Stock Trading Lower Today? - McKesson (NYSE:MCK)
McKesson beats expectations with Q3 2024 sales of $80.9 billion, up 15%. U.S. Pharmaceutical Segment thrives, adjusted EPS at $7.74, exceeding consensus.
Source: benzinga.com
Technology Solutions Segment News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Technology Solutions Segment. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Technology Solutions Segment Today - Breaking & Trending Today